ACRES Announces Second Phase of Collaborative IT Platform to Support Clinical Research
Celltrion and Medidata
Celltrion Adopts Medidata Clinical Cloud
Medidata's ClinicalCloud will provide scalable technology to Celltrion's biosimilars development programs.
Optum, Parexel Will Offer EHR-Fueled and Hybrid Studies
The alliance will offer hybrid studies that combine existing data from electronic health records (EHRs) and medical claims (from Optum) with global, site-based clinical research (Parexel).
Optum and PAREXEL to Accelerate Drug Development, Reimbursement and Market Access with EHR-Fueled Clinical Research and Hybrid Studies
New TMF Maturity Model from Veeva Systems Offers Expert Guidance on Developing and Executing a Strategy to Improve TMF Business Operations
Veeva Offers Complimentary eTMF Consultative Services
The Veeva TMF Maturity Model is available as a self-service online tool or as a more detailed, in-person evaluation with a subject matter expert.
TRI and MCC Integrate RBM Tools
The solution will ‘hand-hold’ companies through the process of performing a protocol risk assessment and developing resulting quality risk management plan.
TRI and the MCC announce the integration
BIOCLINICA ACQUIRE CLINVERSE
BioClinica Acquires Clinverse
The acquisition adds Clinverse’s automated financial management technology solutions to Bioclinica’s portfolio of solutions.
Top 3 Patient-Centric Payment Trends
When paying and reimbursing clinical research volunteers for study participation, what can be done to make the experience more patient centric?
Has the Crunch Come on Healthcare Spending?
Telling signs from U.S., Russia, Latin America and UK indicate that governments are squeezing as much value as possible out of their spending on pills and procedures.
ICON’s Flex Advantage IRT Platform
Flex Advantage offers enhanced randomization and clinical supply management capabilities to support adaptive trials.
ICON Releases Flex Advantage
Patient Death Reported in French Painkiller Trial
Private laboratory Biotrial was testing a pain and mood disorder medication for Portuguese pharma company Bial on humans for the first time, in a Phase I trial.
Clinical Trials Pros Aren't Up to Speed on Endpoint Adjudication Solutions
As in other needs in the clinical trials chain, endpoint adjudication is an area that can be greatly improved by technology.
Latest Business, People News
The latest people and business news includes ACRO appointments and awards for CROs and service providers.
HISTORIC NATIONAL COALITION FORMED TO ACCELERATE NEXT GENERATION IMMUNOTHERAPY IN CANCER
Cancer MoonShot 2020 Targets Drug Development Inefficiencies
Amgen, Celgene, Independence Blue Cross, Bank of America and many more collaborate to deliver immunotherapies more quickly to cancer patients through historic drug development alliance.
BSI Joins ACRES’ Site Accreditation and Standards Initiative
BSI, with a long history of publishing multi-industry standards, intends to help develop and implement standards of excellence for clinical research sites.
BSI and ACRES Developing Global Accreditation Standards for Clinical Research Sites
Certara Launches a Strategic Drug Development Consulting Company in China
New Clinic in Miami Extends inVentiv Health Phase I Services to the U.S.
Certara Launches Consulting in China
Move helps biosimulation consulting support for clients in China, as well as support China's expansion of its fast-track drug approval process.
inVentiv Health Launches Phase I Services to the U.S.
New Phase I clinical in Miami offers gateway location to Latin America.
Bracket Announces the Newest Release of Rater Station
Bracket Releases Rater Station 4.0 eCOA Solution
The Rater Station℠ platform has been used extensively in Central Nervous System clinical trials, and version 4.0 is currently being used in two clinical trials that are actively recruiting.
Assign Clinical Research Joins Celerion
Celerion Expands Service Offerings
Early stage development research provider Celerion announced that Vienna, Austria-based Assign Clinical Research has joined the company.